Designed for executives of early and emerging growth companies, this program at The MedTech Conference includes interactive discussions with successful medtech executives and their partners and features a MedTech Innovator competition with start-ups vying for the MTI Execution Award and Virginia Shimer Rybski Award. This year, the Accel Leadership Seminar will be part of a pre-conference virtual program on Tuesday, September 21, and Wednesday, September 22, 2:00pm ET - 3:30pm ET on each day.
AdvaMed Accel Leadership Seminar - Part II: Here to Stay: How Hybrid Engagements Accelerate Innovation for Med Affairs and Commercial Teams
In February 2021, U.S. FDA announced the agency ''approved, cleared, or authorized a record high of 132 novel medical devices in 2020, surpassing the 40-year high mark we set in 2018 and capping off 10 years of progress.'' In a remarkable display of agility, medtech affairs and commercial teams, including KOLs, and regulatory bodies found a way to advance and deliver innovations in a time of unprecedented disruption. This achievement was made possible in part by accelerating adoption of virtual engagement tools that kept medical affairs, commercial teams, customers and patients engaged.
As teams adapt to a post-Covid world, how can virtual engagement increase its value provision to medical affairs and commercial teams further accelerating commercialization? What strategies and tools should senior leadership of global medtech companies embrace as a hybrid approach to medical affairs and commercial programs becomes the norm and starts to mature?